Tagged with B

Global Recently appointed ISPOR President Eberechukwu Onukwugha, PhD, lays out her inclusive vision for the organisation’s future, championing health economic and outcomes research excellence and innovation that works for all. The original version of this article featured in the July/August edition of ISPOR’s Value & Outcomes Spotlight magazine.   As I…

Mexico Johannes Hauser, managing director of the German-Mexican Chamber of Commerce and Industry (AHK Mexico, or CAMEXA locally), shares the chamber’s functions, which include representing the German private sector in Mexico, with a predominance in the pharmaceutical and medical device industries. In addition, he weighs in on the evolution of German…

Saudi Arabia Attracting, developing, and retaining talented workers – both Saudi and foreign – is perhaps the key sticking point to Saudi Arabia achieving its ambitious transformation targets. Thus far this has involved both ‘carrot’ and ‘stick’ initiatives, ranging from tax incentives and specialised training programs on one side, to mandatory ‘Saudization’…

Hong Kong One year since our last conversation, the Hong Kong Institute of Biotechnology’s Gina Jiang introduces the significant strides made in setting up a GMP facility for CAR-T cell therapy manufacturing at HKIB. Regulatory frameworks have now been developed to support clinical trials and the rollout of advanced therapies. Jiang highlights…

Mexico Gisela Ayala outlines the Mexican Diabetes Federation’s focus on educating people with diabetes, healthcare providers, and the general public to dispel myths and improve diabetes management. She highlights the significant progress in diabetes management technology as well as the challenges of ensuring equitable access to these innovations, and her priorities…

China Despite an adverse funding panorama and looming geopolitical tensions, Chinese biotech is still thriving. Companies originating in China are advancing promising pipelines, going public, looking beyond China’s borders with a record 63 cross-region out-licensing deals in 2023, and attracting the attention of global pharma. Recent PharmaBoardroom interviewees weigh in on…

China CanSinoBIO was established to create high-quality, affordable vaccines for developing countries, addressing global health disparities. Having already developed an inhalable COVID-19 vaccine, the Chinese firm is now working on new TB and polio vaccines using advanced technologies. CEO and Chairman Yu Xuefeng outlines CanSino’s approach to IP protection and sharing,…

Saudi Arabia The Batterjee Group evolved from medical distribution in the 1920s to pioneering the first pharmacy chain in Saudi Arabia and establishing the largest private hospital network in the Middle East. They are expanding further into Asia and other regions, diversifying into areas like medical education, fitness, and IT healthcare solutions.…

Saudi Arabia Saudi Arabia’s Local Content & Government Procurement Authority (LCGPA) aims to enhance local economic growth by increasing domestic expenditure through strategic government procurement. The organization’s mission is to promote knowledge-based policies and tools, ensuring that local content development is prioritized across all sectors, particularly healthcare, in alignment with Saudi Vision…

Saudi Arabia Saudi Arabia has made major progress on the road to implementing the healthcare reforms set out in its Vision 2030. Assistant Minister of Health Dr Mohammed Alabdulaali speaks to PharmaBoardroom about that progress and plans to further pursue the Kingdom’s digital transformation, integrate preventive care and expand healthcare infrastructure. Additionally,…

Saudi Arabia Dr Mahmoud Alyamani, Health & Well-Being Sector Head at NEOM, the sustainable region taking shape in northwest Saudi Arabia. He discusses NEOM’s innovative healthcare vision, emphasizing a proactive, data-driven approach using digital twins and AI. He also highlights the importance of global partnerships to co-create advanced health solutions and NEOM’s…

Saudi Arabia After various leadership roles at Takeda over the course of ten years, Khaled Sary has taken on the position of general manager for the West Gulf cluster, which encompasses Saudi Arabia, Qatar, Oman and Bahrain. In conversation with PharmaBoardroom, Sary discusses the significant growth the Japanese pharma has seen in…